Lupus Clinical Trials in Los Angeles

Showing 61-80 of 171 trials

Study Using Negative Pressure to Reduce Apnea

NCT04861038

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adult subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy.

Sleep Apnea, ObstructiveApnea, Sleep

Sommetrics, Inc.900 participantsStarted Nov 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

AD816 Crossover Study

NCT05793684

The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.

OSAObstructive Sleep Apnea

Apnimed25 participantsStarted Apr 2023

Los Angeles, California, United States • Boston, Massachusetts, United States • St Louis, Missouri, United States

Study Using Negative Pressure to Reduce Apnea

AD816 Crossover Study

Lupus Trials in Other Cities

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Magnetic Resonance Imaging in Obstructive Sleep Apnea

A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

Taking Brain Monitoring to the Next Level

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

An Exploratory Investigation of a Supplement to Enhance Sleep Quality and Quantity

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

Other Conditions in Los Angeles